Rafael (NYSE:RFL – Get Free Report) and CaliberCos (NASDAQ:CWD – Get Free Report) are each small-cap medical firms, however which is the superior enterprise? We are going to distinction the 2 firms primarily based on the power of their analyst suggestions, valuation, earnings, profitability, institutional possession, threat and dividends.
Analyst Suggestions
It is a breakdown of latest suggestions and worth targets for Rafael and CaliberCos, as reported by MarketBeat.com.
| Promote Scores | Maintain Scores | Purchase Scores | Robust Purchase Scores | Ranking Rating | |
| Rafael | 0 | 0 | 0 | 0 | N/A |
| CaliberCos | 0 | 0 | 0 | 0 | N/A |
Profitability
This desk compares Rafael and CaliberCos’ web margins, return on fairness and return on belongings.
| Web Margins | Return on Fairness | Return on Belongings | |
| Rafael | -5,329.44% | -36.57% | -34.92% |
| CaliberCos | -19.84% | -17.74% | -5.61% |
Threat & Volatility
Rafael has a beta of 1.08, suggesting that its inventory worth is 8% extra risky than the S&P 500. Comparatively, CaliberCos has a beta of 0.55, suggesting that its inventory worth is 45% much less risky than the S&P 500.
Insider and Institutional Possession
11.3% of Rafael shares are owned by institutional buyers. Comparatively, 4.1% of CaliberCos shares are owned by institutional buyers. 9.7% of Rafael shares are owned by firm insiders. Comparatively, 42.3% of CaliberCos shares are owned by firm insiders. Robust institutional possession is a sign that hedge funds, giant cash managers and endowments consider a inventory will outperform the market over the long run.
Valuation and Earnings
This desk compares Rafael and CaliberCos”s top-line income, earnings per share (EPS) and valuation.
| Gross Income | Worth/Gross sales Ratio | Web Earnings | Earnings Per Share | Worth/Earnings Ratio | |
| Rafael | $540,000.00 | 83.25 | -$1.88 million | ($1.20) | -1.53 |
| CaliberCos | $90.94 million | 0.16 | -$12.70 million | ($0.67) | -0.99 |
Rafael has greater earnings, however decrease income than CaliberCos. Rafael is buying and selling at a decrease price-to-earnings ratio than CaliberCos, indicating that it’s presently the extra inexpensive of the 2 shares.
Abstract
CaliberCos beats Rafael on 7 of the 11 components in contrast between the 2 shares.
About Rafael
Rafael Holdings, Inc. primarily engages in holding pursuits in medical and early-stage pharmaceutical firms, and industrial actual property belongings in the USA and Israel. It operates in two segments, Healthcare and Actual Property. The corporate engages within the growth and commercialization of therapies that exploit the metabolic variations between regular cells and most cancers cells. Its lead drug candidate is CPI-613 (devimistat), presently below Part III medical research for the remedy of metastatic pancreatic most cancers and acute myeloid leukemia. The corporate can also be concerned in creating Promitil, a molecule designed for the focused supply of mitomycin-C in a proprietary prodrug type, accomplished Part 1B medical research; Folate-targeted Promitil (Promi-Fol) which is geared toward native remedy (intravesical) of superficial bladder most cancers; and Promi-Dox, a extremely potent twin drug liposome with MLP and doxorubicin concentrating on a possible basket of tumors. As well as, it engages within the growth of surgical and procedural gadgets, together with orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was included in 2017 and is headquartered in Newark, New Jersey.
About CaliberCos
Caliber (NASDAQ: CWD) is a vertically built-in different asset administration agency whose objective is to construct generational wealth for buyers in search of to entry alternatives in middle-market belongings. Caliber differentiates itself by creating, managing, and servicing proprietary merchandise, together with middle-market funding funds, personal syndications, and direct investments that are managed by our in-house asset companies group. Our funds embody funding autos centered totally on actual property, personal fairness, and debt services. Extra info may be discovered at Caliberco.com and CaliberFunds.co.
Obtain Information & Scores for Rafael Day by day – Enter your e-mail tackle under to obtain a concise every day abstract of the newest information and analysts’ scores for Rafael and associated firms with MarketBeat.com’s FREE every day e-mail publication.
